YAG Laser Versus Punch Biopsy for the Treatment of Tattoo Skin Markers

Tattoo Skin Markers Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00271674
• Other study ID #: KF-01-275533
• Status: Completed
• Phase: N/A
• First received: January 3, 2006
• Last updated: June 2, 2008
• Start date: January 2006
• Est. completion date: December 2007

Study information

• Verified date: June 2008
• Source: Bispebjerg Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: Denmark: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

The purpose of the study is to compare patient satisfaction, clinical efficacy and adverse effects of Q-switched YAG laser versus punch biopsies for the treatment of tattoo dots that are applied as skin markers in relation to X-ray treatment of malignant disorders.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: December 2007
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• 18 years or older,

• Skin types I-IV,

• No previous laser treatment for the condition.

Exclusion Criteria:

• Younger than 18 years,

• Skin types V-VI,

• Pregnant or lactating women,

• Previous laser treatment for the condition,

• Recent exposure to sun or sun-beds,

• Treatment with oral retinoids within 3 months,

• Tendency to produce hypertrophic scars or keloids,

• Immunosuppressive treatment or disorders

Study Design

Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Tattoo Skin Markers

Intervention

Device:
• Q-switched YAG laser

Locations

Country	Name	City	State
Denmark	Bispebjerg Hospital	Copenhagen	Copenhagen NV

Sponsors (1)

Lead Sponsor	Collaborator
Bispebjerg Hospital

Country where clinical trial is conducted

Denmark,